YOLFTbeta
Inst Diagnosti

Inst Diagnosti

INDISA · SN · Healthcare / Medical Care Facilities

2,280.90CLP-12.06 (-0.53%)

Price History

Full chart

Market Stats

Previous Close2,292.96
Open2,276.80
Day Range2,265.60 – 2,288.70
52-Week Range2,337.83 – 2,847.98
Volume11.33K
Market Cap387.57B
P/E (TTM)28.90
Forward P/E14.81
EPS86.14
Dividend Yield1.61%
Beta0.39
50-Day Avg2,534.88
200-Day Avg2,623.43

About

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising online consultation and rehabilitation. In addition, it operates health centers, which includes metabolic surgery and nutrition, thyroid and parathyroid, physical medicine and rehabilitation, endometriosis, hemodynamics service, and dialysis centers, as well as provide insurance products. Further, the company offers research and training services, as well as newborn, school, and accident agreements. Instituto de Diagnóstico S.A. was founded in 1961 and is headquartered in Providencia, Chile.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Manuel Serra Cambiaso
  • Employees3.11K
  • HeadquartersAvda. Santa MarIa 1810, Providencia, Chile, Chile
  • Websitehttps://www.indisa.cl

Leadership

  • Mr. Manuel Serra CambiasoGeneral Manager
  • Mr. Alejandro Milad PalaneckAdministration and Finance Manager
  • Mr. Julio Cano BarrigaOperations Manager
  • Ms. Cecilia Palma OjedaHuman Resources Manager

Financials

Income Statement

Currency: CLP2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue103.63B116.94B128.31B138.35B145.41B150.19B139.36B188.54B191.29B218.93B239.07B272.31B
Growth (%)-+12.85%+9.72%+7.83%+5.10%+3.28%-7.21%+35.30%+1.46%+14.45%+9.20%+13.90%
Cost of Revenue71.18B82.06B90.61B98.74B103.97B109.99B110.06B137.86B145.78B174.05B180.96B201.63B
Gross Profit32.45B34.88B37.69B39.61B41.44B40.20B29.30B50.69B45.51B44.89B58.11B70.68B
Gross Margin31.31%29.83%29.38%28.63%28.50%26.77%21.03%26.88%23.79%20.50%24.31%25.96%
Operating Expense16.54B17.65B20.94B22.80B23.73B24.54B23.95B28.24B32.56B40.69B43.46B58.11B
Operating Income15.91B17.23B16.76B16.82B17.71B15.66B5.35B22.45B12.95B4.20B14.65B12.57B
Operating Margin15.35%14.74%13.06%12.15%12.18%10.43%3.84%11.91%6.77%1.92%6.13%4.62%
EBITDA---18.47B23.41B18.56B7.61B28.05B18.44B7.10B16.53B32.32B
EBITDA Margin---13.35%16.10%12.36%5.46%14.88%9.64%3.24%6.91%11.87%
Net Income11.73B13.13B12.93B11.89B14.70B11.63B3.50B20.65B13.05B144.31M7.28B15.66B
Net Income Margin11.32%11.23%10.08%8.59%10.11%7.74%2.51%10.95%6.82%0.07%3.04%5.75%
Interest Expense00003.37B3.11B2.83B2.62B4.75B8.61B7.62B7.45B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%2.32%2.07%2.03%1.39%2.48%3.93%3.19%2.73%

Balance Sheet

Currency: CLP2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets111.69B135.42B154.22B159.86B163.50B168.49B182.72B230.88B272.96B276.57B272.44B409.11B
Total Liabilities61.53B78.69B91.16B90.86B87.42B86.58B97.90B135.71B171.26B172.56B163.28B201.84B
Total Equity50.13B56.73B63.05B69.00B76.08B81.92B84.82B95.17B101.70B104.02B109.16B207.27B
Cash12.27B16.15B16.66B14.33B17.77B13.58B15.06B9.75B14.19B12.76B10.65B17.66B
Net Debt---34.18B27.51B32.81B40.71B66.58B84.61B86.14B82.80B70.60B

Cash Flow

Currency: CLP2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow13.58B15.05B11.57B14.89B14.75B10.66B14.46B14.83B----
Investing Cash Flow-5.66B-15.78B-8.90B-8.23B21.95M-6.11B-12.89B-32.72B----
Financing Cash Flow-5.36B4.61B-2.16B-9.00B-11.33B-8.74B-79.78M12.57B----
Capital Expenditure6.03B12.30B9.73B8.63B4.72B7.44B12.45B31.45B24.14B8.73B2.65B3.82B
Free Cash Flow---5.75B9.38B3.09B-1.70B-19.07B-2.36B9.30B16.65B21.64B
Dividends Paid5.29B5.86B6.57B6.47B5.94B7.35B4.65B1.75B10.32B3.92B43.69M2.18B
FCF to OCF---38.61%63.54%28.98%-11.78%-128.61%----
Dividend Paid to FCF---112.48%63.40%237.85%-273.02%-9.16%-437.71%42.11%0.26%10.09%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 24, 2021May 26, 2021Jun 30, 2021Nov 24, 2021Mar 23, 2022May 25, 2022Sep 8, 2022Nov 23, 2022Mar 22, 2023May 24, 2023Sep 7, 2023Sep 30, 2023Mar 27, 2024Mar 31, 2024Sep 5, 2024Nov 27, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------
EPS Actual7.4010.6611.6611.9015.0511.6910.4711.8315.0613.3017.1216.1220.4218.3320.8518.2221.9518.7218.1519.6724.7626.7022.7921.2625.8518.0414.0322.3326.1818.3015.5838.0928.7317.5216.4323.0825.1114.457.95-15.827.9724.7431.7333.3439.7140.2940.2534.4818.86-0.99-19.306.041.7312.484.0519.6213.9113.2913.5333.8917.6038.231.5424.09
Surprise----------------------------------------------------------------
Timing-----------------------------------------After-hours--Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-marketPre-market-------

Key Statistics & Ratios

Market Cap387.57B
Enterprise Value515.14B
Trailing P/E28.90
Forward P/E14.81
Price / Sales1.35
Price / Book1.80
EPS86.14
Book Value1,457.27
Revenue (TTM)286.93B
Gross Profit (TTM)74.34B
EBITDA31.95B
Profit Margin4.42%
Operating Margin9.54%
Return on Equity7.51%
Return on Assets3.92%
Shares Outstanding155.69M
Shares Float75.80M
Beta0.39
Dividend Yield1.61%
Dividend Rate41.69
Payout Ratio51.17%

Dividends

20261×
41.69May 19, 2026
20251×
14.85May 12, 2025
20241×
0.30May 13, 2024
20231×
0.02May 15, 2023
20221×
70.14May 11, 2022
20211×
4.70Apr 30, 2021
20201×
23.76Apr 30, 2020
20191×
19.93May 3, 2019
20181×
16.19Apr 27, 2018
20171×
17.58May 5, 2017
20161×
26.79May 4, 2016
20151×
15.94May 4, 2015
20141×
14.41May 5, 2014
20131×
10.19May 6, 2013
20121×
9.53May 3, 2012
20111×
22.13May 5, 2011
20101×
6.03May 3, 2010
20091×
4.91May 4, 2009
20081×
5.39Apr 28, 2008
20071×
4.16May 16, 2007

Stock Splits

  • Nov 5, 20262739:2738
  • Sep 14, 2026896:883
  • Sep 10, 20251167:1165
  • Jul 23, 2025884:861
  • Mar 12, 20181597:913